Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel

Intrinsic or acquired chemoresistance is a hurdle in oncology. Only 7%–16% of estrogen receptor α (ERα) positive breast cancer cases achieve a pathological complete response (pCR) after neo-adjuvant chemotherapy. Nogo-B receptor (NgBR) is a cell surface receptor that binds farnesylated Ras and promo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Lett
Main Authors: Jin, Ying, Hu, Wenquan, Liu, Tong, Rana, Ujala, Aguilera-Barrantes, Irene, Kong, Amanda, Kumar, Suresh N., Wang, Bei, Gao, Pin, Wang, Xiang, Duan, Yajun, Shi, Aiping, Song, Dong, Yang, Ming, Li, Sijie, Han, Bing, Zhao, Gang, Fan, Zhimin, Miao, Qing Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821135/
https://ncbi.nlm.nih.gov/pubmed/29373839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.01.054
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados